Total Payments
$6,971
2024 Payments
$2,199
Companies
37
Transactions
508
Medicare Patients
3,293
Medicare Billing
$90,275
Payment Breakdown by Category
Food & Beverage$6,971 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,971 | 508 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,391 | 140 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $828.20 | 17 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $811.27 | 36 | $0 (2024) |
| Novo Nordisk Inc | $750.56 | 116 | $0 (2024) |
| Lilly USA, LLC | $418.65 | 35 | $0 (2023) |
| Amgen Inc. | $405.13 | 44 | $0 (2024) |
| PFIZER INC. | $262.50 | 22 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $228.94 | 17 | $0 (2024) |
| Axsome Therapeutics, Inc. | $200.30 | 6 | $0 (2024) |
| Amarin Pharma Inc. | $142.66 | 10 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,199 | 155 | ABBVIE INC. ($449.51) |
| 2023 | $2,093 | 145 | ABBVIE INC. ($539.93) |
| 2022 | $1,616 | 118 | Boehringer Ingelheim Pharmaceuticals, Inc. ($282.13) |
| 2021 | $1,064 | 90 | Novo Nordisk Inc ($214.37) |
All Payment Transactions
508 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $6.63 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.87 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $4.00 | General |
| Category: PAIN | ||||||
| 11/22/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.55 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $5.15 | General |
| Category: Inflammation | ||||||
| 11/19/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $30.24 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Cardio-renal | ||||||
| 11/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: DIABETES | ||||||
| 11/06/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Bone Health | ||||||
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: DIABETES | ||||||
| 11/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $7.33 | General |
| Category: Inflammation | ||||||
| 11/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $5.37 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $3.41 | General |
| Category: PAIN | ||||||
| 11/05/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Durable Pump | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $7.57 | General |
| Category: Obesity | ||||||
| 10/30/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $6.53 | General |
| Category: Inflammation | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: RESPIRATORY | ||||||
| 10/28/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $8.66 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Diabetes | ||||||
| 10/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $5.92 | General |
| Category: Cardiology | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Respiratory | ||||||
| 10/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $6.90 | General |
| Category: Inflammation | ||||||
| 10/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Cardio-renal | ||||||
| 10/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 736 | 1,073 | $60,092 | $23,661 |
| 2022 | 21 | 815 | 1,003 | $70,142 | $24,431 |
| 2021 | 21 | 919 | 1,067 | $60,270 | $25,187 |
| 2020 | 20 | 823 | 1,222 | $53,540 | $16,996 |
Total Patients
3,293
Total Services
4,365
Medicare Billing
$90,275
Procedure Codes
79
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 89 | 151 | $23,254 | $10,025 | 43.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 25 | $5,413 | $2,451 | 45.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 37 | $4,012 | $1,613 | 40.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 86 | 132 | $5,280 | $1,359 | 25.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 72 | 104 | $4,680 | $1,342 | 28.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 85 | 141 | $1,410 | $1,171 | 83.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $2,990 | $1,150 | 38.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 41 | 59 | $2,478 | $959.72 | 38.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 82 | 116 | $2,436 | $877.48 | 36.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 44 | 76 | $1,596 | $723.52 | 45.3% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 41 | 59 | $2,065 | $515.42 | 25.0% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 14 | 21 | $1,302 | $463.26 | 35.6% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 45 | 57 | $570.00 | $348.27 | 61.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 12 | 12 | $432.00 | $342.00 | 79.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 24 | 29 | $1,044 | $175.59 | 16.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 17 | 18 | $900.00 | $98.45 | 10.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 18 | 23 | $230.00 | $46.86 | 20.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 85 | 112 | $17,040 | $7,469 | 43.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 66 | 76 | $8,067 | $3,711 | 46.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 21 | 22 | $4,580 | $1,944 | 42.4% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 13 | 13 | $13,052 | $1,618 | 12.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $3,680 | $1,404 | 38.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 25 | 26 | $2,600 | $1,215 | 46.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 79 | 101 | $4,040 | $1,052 | 26.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 56 | 65 | $2,925 | $844.07 | 28.9% |
About Amanda Toris, CRNP
Amanda Toris, CRNP is a Family healthcare provider based in Saraland, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/07/2019. The National Provider Identifier (NPI) number assigned to this provider is 1225501836.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amanda Toris, CRNP has received a total of $6,971 in payments from pharmaceutical and medical device companies, with $2,199 received in 2024. These payments were reported across 508 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($6,971).
As a Medicare-enrolled provider, Toris has provided services to 3,293 Medicare beneficiaries, totaling 4,365 services with total Medicare billing of $90,275. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Saraland, AL
- Active Since 01/07/2019
- Last Updated 01/07/2019
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1225501836
Products in Payments
- VRAYLAR (Drug) $938.79
- JARDIANCE (Drug) $780.10
- FARXIGA (Drug) $422.40
- Otezla (Drug) $296.46
- Ozempic (Drug) $283.44
- UBRELVY (Drug) $277.15
- BREZTRI (Drug) $270.23
- Kerendia (Drug) $228.94
- Auvelity (Drug) $200.30
- MOUNJARO (Drug) $193.31
- NURTEC ODT (Drug) $183.38
- Rybelsus (Drug) $165.63
- Wegovy (Drug) $164.05
- Vascepa (Drug) $142.66
- Orphengesic Forte (Drug) $127.51
- QULIPTA (Drug) $125.41
- XIFAXAN (Drug) $124.48
- AIRSUPRA (Drug) $123.09
- WATCHMAN FLX (Device) $113.98
- AFREZZA (Drug) $108.67
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.